SRC and Alzheimer disease: Nine core AD-related genes—SRC, TNF, PTGS2, ESR1, HSP90AA1, NOS3, NR3C1, AR, and SLC6A4—were the most important and interactive targets of the 32 WZY active compounds, as the previous network pharmacology results (Figure 4C) indicated.